Stocks making the biggest moves in the premarket: Tesla, Apple, AstraZeneca and more

for a phase three trial of a lung cancer treatment.

While the drug compared well to a competitor on one endpoint, the data for overall survival was "not mature" and pointed toward to the results being not statistically significant, AstraZeneca said in a press release. The trial will continue, according to the company.

الإمارات العربية المتحدة أحدث الأخبار, الإمارات العربية المتحدة عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Tesla shares rally on delivery numbers, AstraZeneca stock slumps on drug trial, and other stocks on the moveTesla and AstraZeneca stock head in opposite directions.
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »

Recession will take shine off stocks' AI-fueled rally in H2: HSBCUS stocks face a painful rest of 2023 with a recession set to take the shine off the AI-fueled rally, HSBC says
مصدر: BusinessInsider - 🏆 729. / 51 اقرأ أكثر »